These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 25737042)

  • 1. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
    Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
    J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease.
    Faria MC; Gonçalves GS; Rocha NP; Moraes EN; Bicalho MA; Gualberto Cintra MT; Jardim de Paula J; José Ravic de Miranda LF; Clayton de Souza Ferreira A; Teixeira AL; Gomes KB; Carvalho Md; Sousa LP
    J Psychiatr Res; 2014 Jun; 53():166-72. PubMed ID: 24576746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
    Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article.
    Fang Y; Du N; Xing L; Duo Y; Zheng L
    Medicine (Baltimore); 2019 Jul; 98(30):e16604. PubMed ID: 31348306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and BDNF serum levels.
    Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
    Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
    Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
    Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
    Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
    J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).
    Qin XY; Cao C; Cawley NX; Liu TT; Yuan J; Loh YP; Cheng Y
    Mol Psychiatry; 2017 Feb; 22(2):312-320. PubMed ID: 27113997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.
    Angelucci F; Spalletta G; di Iulio F; Ciaramella A; Salani F; Colantoni L; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Bossù P
    Curr Alzheimer Res; 2010 Feb; 7(1):15-20. PubMed ID: 20205668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
    Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
    BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.
    Teixeira AL; Diniz BS; Campos AC; Miranda AS; Rocha NP; Talib LL; Gattaz WF; Forlenza OV
    Neuromolecular Med; 2013 Mar; 15(1):115-21. PubMed ID: 23055000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased N200 and P300 latencies in cognitively impaired elderly carrying ApoE ε-4 allele.
    Cintra MTG; Ávila RT; Soares TO; Cunha LCM; Silveira KD; de Moraes EN; Simas KR; Fernandes RB; Gonçalves DU; de Rezende NA; Bicalho MAC
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):e221-e227. PubMed ID: 28833437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    Forlenza OV; Diniz BS; Teixeira AL; Radanovic M; Talib LL; Rocha NP; Gattaz WF
    Neuromolecular Med; 2015 Sep; 17(3):326-32. PubMed ID: 26138246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the Relationship between Cerebral Blood Perfusion, Neuronal Cytokines and Cognitive Function in Patients with Alzheimer's Disease.
    Lu H; Fang Y; Chen X; Zhang W; Wang Y
    Actas Esp Psiquiatr; 2024 Jun; 52(3):238-247. PubMed ID: 38863048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.
    Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU
    J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of dexmedetomidine and placebo on the plasma concentrations of NGF, BDNF, GDNF, and epinephrine during severe alcohol withdrawal.
    Reynolds PM; Mueller SW; MacLaren R
    Alcohol; 2015 Feb; 49(1):15-9. PubMed ID: 25638740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer's disease in patients with the apolipoprotein E ϵ4 genotype.
    Wang C; Cui Y; Yang J; Zhang J; Yuan D; Wei Y; Li Y; Duo Y; Li S; Zhu W; Zheng L
    Biomarkers; 2015 Feb; 20(1):84-8. PubMed ID: 25532446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum neurotrophin levels related to alcohol use disorder in a young population sample.
    Lhullier AC; Moreira FP; da Silva RA; Marques MB; Bittencourt G; Pinheiro RT; Souza LD; Portela LV; Lara DR; Jansen K; Wiener CD; Oses JP
    Alcohol Clin Exp Res; 2015 Jan; 39(1):30-3. PubMed ID: 25623403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.